DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
CYR-101 is an investigational drug.
There have been 4 clinical trials for CYR-101. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2007.
The most common disease conditions in clinical trials are Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Cyrenaic Pharmaceuticals, Pusan National University Hospital, and Novartis Pharmaceuticals.
Recent Clinical Trials for CYR-101
|Vasodilators and Anti-Oxidant Therapy in Early ATN||Dialysis Clinic, Inc.||Phase 2/Phase 3|
|Vasodilators and Anti-Oxidant Therapy in Early ATN||Southeast Renal Research Institute||Phase 2/Phase 3|
|Study of CYR-101 in Patients With Schizophrenia||Cyrenaic Pharmaceuticals||Phase 2|